Everand Logo

Welcome to Everand!

  • STAT

    Listen: A whirlwind week in Washington, Sean Parker’s mansion, & remembering a resonant voice in biotech

    The latest episode of STAT's #biotech #podcast, "The Readout LOUD," is here. Listen now:
    by Damian Garde and Rebecca Robbins Jul 11, 2019 1 minute

    Is drug pricing too complex for the Trump administration? Would you recognize Tom Hanks at a party? And what does it mean when famous

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About Plans For Generic Wegovy, Cough Syrup Warnings, And More
    Biocon is developing a generic version of Novo Nordisk's Wegovy and is prepared to conduct a clinical trial next year if needed.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About Cigna Biosimilar Plans, A Vertex Deal In South Africa, And More
    Cigna plans to make copies of AbbVie's Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About MorphoSys Drug Risks, An AstraZeneca Admission, And More
    MorphoSys is dealing with a safety issue with pelabresib, the experimental treatment for myelofibrosis and centerpiece of its proposed $3 billion acquisition by Novartis.

    Related Books & Audiobooks